The SAIR database is designed to help scientists train AI models to better predict protein-ligand binding affinities for drug ...

AI-powered ChemPerturb-seq reveals sex-specific cocktail improving islet transplant survival, offering a new treatment for type 1 diabetes.

Moving toward clinical development, the researchers demonstrated efficient delivery of mRNA mitochondrial base editors using lipid nanoparticles.

An iPSC-based ALS-on-a-chip model that mimics disease progression and reveals altered glutamate signaling in motor neurons ...

Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.

EM, researchers elucidated the structure of key receptors integral to fast excitatory synaptic transmission in the rat cerebellum.

The question for biomanufacturing leaders is no longer whether to modernize their scientific data infrastructure, but how ...

A recent research finding adds to evidence that brain inflammation is a major driver of neurodegenerative disorders such as ...

A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.

Illumina has entered into a definitive agreement with Standard BioTools under which the company will acquire SomaLogic.

LOTTE will manufacture antibody drug substance for Ottimo Pharma’s product at LOTTE’s Syracuse Bio Campus in New York.